Overview

Randomized Cross Over Study to Assess Efficacy and Safety of BDP/FF and Glycopyrrolate

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
dose-finding study to assess the optimal dose of glycopyrrolate daily dose on top of BDP/FF in COPD patients.
Phase:
Phase 2
Details
Lead Sponsor:
Chiesi Farmaceutici S.p.A.
Treatments:
Glycopyrrolate